Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework. | Circ Genom Precis Med | 2021 | 33831308 | PubTator, text mining | PubMed |
| Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells. | Int J Mol Sci | 2021 | 33809429 | PubTator, text mining | PubMed |
| Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in Therapy. | Pharmaceutics | 2021 | 33806707 | PubTator, text mining | PubMed |
| Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes. | Int J Mol Sci | 2021 | 33805011 | PubTator, text mining | PubMed |
| Genetic Cardiomyopathies: The Lesson Learned from hiPSCs. | J Clin Med | 2021 | 33803477 | PubTator, text mining | PubMed |
| Nitrosative Redox Homeostasis and Antioxidant Response Defense in Disused Vastus lateralis Muscle in Long-Term Bedrest (Toulouse Cocktail Study). | Antioxidants (Basel) | 2021 | 33802593 | PubTator, text mining | PubMed |
| LncRNAs in Cardiomyocyte Maturation: New Window for Cardiac Regenerative Medicine. | Noncoding RNA | 2021 | 33802186 | PubTator, text mining | PubMed |
| Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease. | Int J Mol Sci | 2021 | 33799647 | PubTator, text mining | PubMed |
| The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies. | Int J Mol Sci | 2021 | 33799487 | PubTator, text mining | PubMed |
| Expanding the phenotype of CACNA1C mutation disorders. | Mol Genet Genomic Med | 2021 | 33797204 | PubTator, text mining | PubMed |
| The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading? | Front Cell Dev Biol | 2021 | 33796531 | PubTator, text mining | PubMed |
| Increased Reactive Oxygen Species-Mediated Ca2+/Calmodulin-Dependent Protein Kinase II Activation Contributes to Calcium Handling Abnormalities and Impaired Contraction in Barth Syndrome. | Circulation | 2021 | 33793303 | PubTator, text mining | PubMed |
| Proteomics study on the effect of silybin on cardiomyopathy in obese mice. | Sci Rep | 2021 | 33785854 | PubTator, text mining | PubMed |
| Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy. | Clin Transl Med | 2021 | 33784018 | PubTator, text mining | PubMed |
| Novel circular RNA circSOBP governs amoeboid migration through the regulation of the miR-141-3p/MYPT1/p-MLC2 axis in prostate cancer. | Clin Transl Med | 2021 | 33784000 | PubTator, text mining | PubMed |
| Intramyocardial Transplantation of Human iPS Cell-Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals. | JACC Basic Transl Sci | 2021 | 33778211 | PubTator, text mining | PubMed |
| TNNI3 and KCNQ1 co-inherited variants in a family with hypertrophic cardiomyopathy and long QT phenotypes: A case report. | Mol Genet Metab Rep | 2021 | 33777698 | PubTator, text mining | PubMed |
| The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro. | Front Pharmacol | 2021 | 33776763 | PubTator, text mining | PubMed |
| Growth Hormone Releasing Hormone in Endothelial Barrier Function. | Trends Endocrinol Metab | 2021 | 33771415 | PubTator, text mining | PubMed |
| Activation of AMPK Promotes Maturation of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells. | Front Cell Dev Biol | 2021 | 33768096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=56